Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hisashi Yamanaka
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes From the 24-Month Phase 3 ORAL Scan Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Effectiveness, Safety, and Methotrexate Dose-Tapering Pattern Over Two Years of Treatment With Adalimumab and ≥12 Mg/Week Methotrexate for Early Rheumatoid Arthritis: Results of the HAWK Postmarketing Surveillance Study in Japan
Modern Rheumatology
Medicine
Rheumatology
Efficacy and Safety of Sirukumab in Japanese Patients With Moderate to Severe Rheumatoid Arthritis Inadequately Controlled by Disease Modifying Anti-Rheumatic Drugs: Subgroup Analysis of a Phase 3 Study
Modern Rheumatology
Medicine
Rheumatology
Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study
Modern Rheumatology
Medicine
Rheumatology
Efficacy and Safety of Tofacitinib in Japanese Patients With Rheumatoid Arthritis by Background Methotrexate Dose: A Post-Hoc Analysis of Clinical Trial Data
Modern Rheumatology
Medicine
Rheumatology
A Large Observational Cohort Study of Rheumatoid Arthritis, IORRA: Providing Context for Today’s Treatment Options
Modern Rheumatology
Medicine
Rheumatology
Experimental Immunology Tumor Necrosis Factor-Α and Matrix Metalloproteinase-3 Production in Rheumatoid Arthritis Synovial Tissue Is Inhibited by Blocking Gap Junction Communication
Central-European Journal of Immunology
Allergy
Immunology
Tonsillectomy to Effectively Treat a Patient With Behçet's Disease
Internal Medicine
Internal Medicine
Medicine
A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients With Rheumatoid Arthritis
Rheumatology and Therapy
1
2
›
